Donor-Derived Fibrillary Glomerulonephritis (FGN) in Mate-Kidney Allografts (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1159; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "After transitioning to belatacept, his sCr at 3 months post-KT remained suboptimal (3 mg/dL)...He received basiliximab induction, and tacrolimus/mycophenolate/prednisone maintenance...Discussion Although long term outcomes are yet to be determined, small observational studies suggest that long-term FGN recurrence in allografts can reach up to 21%, with minimal impact on kidney function. Our report suggests that donor-derived FGN can be conservatively managed without impact to allograft function."
Colon Cancer • Colorectal Cancer • Fibrosis • Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Hepatology • IgA Nephropathy • Immunology • Inflammatory Bowel Disease • Lupus Nephritis • Nephrology • Solid Tumor • Ulcerative Colitis
|
|
Kenneth Brand; Eric Jia Yi Xu; Bhavna Chopra; Mary Ann C. Lim; Joel M. Henderson; Matthew Palmer
|